🚀
Enjoy a 7-Day Free Trial Thru Dec 20, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Drug Manufacturers
Intra-Cellular Therapies Inc (NAS:ITCI)
News
Intra-Cellular Therapies Inc
1
NAS
:ITCI (USA) Â
$ 83.40
-0.48 (-0.57%)
03:08 AM EST
P/E:
At Loss
P/B:
7.77
Market Cap:
$ 8.89B
Enterprise V:
$ 7.82B
Volume:
393.47K
Avg Vol (2M):
580.89K
Warning! GuruFocus detected 1 Severe warning sign with ITCI.
Try a 7-Day Free Trial
to check it out.
Trade In:
Volume:
393.47K
Market Cap $:
8.89B
PE Ratio:
At Loss
Avg Vol (2M):
580.89K
Enterprise Value $:
7.82B
PB Ratio:
7.77
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Intra-Cellular Therapies Inc (NAS:ITCI) Stock News, Headlines & Updates
Intra-Cellular Therapies Inc Stock News from GuruFocus
Total 19
1
Dec 11, 2024
Intra-Cellular Therapies Inc (ITCI) Presents Promising Data on CAPLYTA for Major Depressive Disorder
GuruFocus News
•
7:01am
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
Marketwired
•
7:00am
Dec 03, 2024
Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy
Marketwired
•
7:00am
Nov 19, 2024
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Marketwired
•
8:00am
Nov 13, 2024
FMR LLC Reduces Stake in Intra-Cellular Therapies Inc
GuruFocus News
•
10:40pm
Nov 07, 2024
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
Marketwired
•
8:00am
Nov 06, 2024
Intra-Cellular Therapies Inc (ITCI) Trading 3.56% Higher on Nov 6
GuruFocus News
•
10:03am
Nov 05, 2024
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
Marketwired
•
6:00am
Oct 31, 2024
Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and Strategic Pipeline Developments
GuruFocus News
•
1:07am
Q3 2024 Intra-Cellular Therapies Inc Earnings Call Transcript
GuruFocus News
•
11:16pm
Oct 30, 2024
Intra-Cellular Therapies Inc (ITCI) Shares Up 12.31% on Oct 30
GuruFocus News
•
11:05am
Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings: Revenue Hits $175.2M, Surpassing Estimates; GAAP EPS at -$0.25
GuruFocus News
•
7:11am
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
Marketwired
•
7:00am
Oct 29, 2024
What To Expect From Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings
GuruFocus News
•
7:05am
Oct 17, 2024
Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast
Marketwired
•
8:00am
Oct 11, 2024
Intra-Cellular Therapies Inc (ITCI) Shares Up 3.21% on Oct 11
GuruFocus News
•
11:04am
Oct 10, 2024
JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc
GuruFocus News
•
1:05pm
Sep 23, 2024
Intra-Cellular Therapies Inc (ITCI) Shares Gap Down to $75.14 on Sep 23
GuruFocus Research
•
11:10am
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
Marketwired
•
8:00am
Total 19
1
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news